Javascript must be enabled to continue!
Genetic background of esophageal squamous cell carcinoma
View through CrossRef
A nyelőcsőrák a kilencedik leggyakoribb rosszindulatú daganat. Több mint 90%-ban előrehaladott állapotban kerül felismerésre. A sebészi beavatkozás, a kemo-, illetve radioterápia lehetőségei korlátozottak. Napjainkban a génterápia került az érdeklődés előterébe. A szerzők a nyelőcsőlaphámrák genetikai és molekuláris hátterét és a génterápiával elért kezdeti tapasztalatokat tekintik át. Ismertetik a komplementer nukleinsavak (antisense terápia), a génpótlás, a kis interferáló RNS-k alkalmazásának lehetőségeit.
Title: Genetic background of esophageal squamous cell carcinoma
Description:
A nyelőcsőrák a kilencedik leggyakoribb rosszindulatú daganat.
Több mint 90%-ban előrehaladott állapotban kerül felismerésre.
A sebészi beavatkozás, a kemo-, illetve radioterápia lehetőségei korlátozottak.
Napjainkban a génterápia került az érdeklődés előterébe.
A szerzők a nyelőcsőlaphámrák genetikai és molekuláris hátterét és a génterápiával elért kezdeti tapasztalatokat tekintik át.
Ismertetik a komplementer nukleinsavak (antisense terápia), a génpótlás, a kis interferáló RNS-k alkalmazásának lehetőségeit.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
Rationale:
To investigate T lymphoma invasion and metastasis inducing factor 2 (Tiam2) protein for expression in esophageal carcinoma and relationship with clinical fea...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Oral Papillary Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: A Histopathological and Immunohistochemical Comparative Study
Oral Papillary Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: A Histopathological and Immunohistochemical Comparative Study
Abstract
Purpose
The aim of the study is to investigate the immunohistochemical expression of both Alpha smooth muscle actin and Transforming Growth...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review
Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review
Background: Endobronchial squamous cell carcinoma is one of the most common types of tumors located inside the tracheobronchial tree. Patients often present in advanced stages of t...
Risk Factors for Esophageal Cancer in the Cohort of Nuclear Facility Workers
Risk Factors for Esophageal Cancer in the Cohort of Nuclear Facility Workers
Purpose: To assess the influence of non-radiation factors and occupational radiation exposure on the incidence risk of esophageal cancer in nuclear workers considering various hist...
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
Abstract
Background
Esophageal squamous cell carcinoma (ESCC) is typically treated with neoadjuvant therapy followed by esophage...


